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Abstract
Objective: The  present  study  aims  to  assess  verbal  memory  performance  in 
patients  with  schizophrenia  attending  HUSM  and  determine  the  relationship 
between the patients’ verbal memory performance and their demographic/clinical 
factors.  Methods: A  cross  sectional  study  of  114  patients  with  schizophrenia 
attending  HUSM  psychiatric  services  from  December  2007  to  May  2008  was 
conducted. The schizophrenia symptoms as well as verbal memory performance 
were assessed using the Brief Psychiatric Rating Scale, the Malay version of the 
Calgary  Depression  Scale  (MVCDS),  and  the  Malay  version  of  the  Auditory 
Verbal  Learning  Test  (MVAVLT).  The  relationship  between  verbal  memory 
performance  and demographic/clinical  symptoms  was  evaluated  using  Pearson 
Correlation.  Results: Overall MVAVLT scores in all  the trials were lowered in 
patients  with schizophrenia  compared to average healthy controls.  There were 
significant relationships between occupational status and MVAVLT performance 
in Trial A1-A5 Total; between educational level and MVAVLT performance in 
Trial A1 and Trial A1-A5 Total and between severities of illness and MVAVLT 
performance in all  indexes except Trial A1 after controlled for occupation and 
educational level.  Conclusions: Patient with schizophrenia in HUSM performed 
significantly  worse  than  healthy  controls  in  verbal  memory  with  or  without 
interference. There were significant relationships between MVAVLT performance 
and patient’s occupational status, educational level and severity of the illness but 
not  depressive  symptoms.  ASEAN  Journal  of  Psychiatry,  Vol.12(2):  July  –  
Keywords: schizophrenia; demographic; Malay version of the Auditory Verbal 
Learning  Test;  Brief  Psychiatric  Rating  Scale;  Malay  version  of  the  Calgary 
Depression Scale
Introduction
Schizophrenia  is  characterized  by  broad 
cognitive impairment, with varying degrees of 
deficit  in  all  ability  domains  measured  by 
standard  clinical  tests  which  include  global 
and  selective  verbal  memory,  nonverbal 
memory and executive function [1]. Study by 
Green in 1996 emphasizes the significance of 
verbal memory for the functional outcome in 
schizophrenia [2] and was proposed to be one 
of  the  main  predictors  of  psychosocial 
functioning [3].
Paulsen  et  al.  (1995)  evaluated  the  potential 
clinical  and  demographic  factors  associated 
with  learning  and  memory  impairment  in 
schizophrenia  and  found  that  patients  with 
schizophrenia  showed  prominent  retrieval 
deficit [4].  They also performed badly on all 
learning,  recall  and  recognition  memory 
measures  and  the  most  important  clinical 
correlates  of  these  impairments  were  earlier 
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age  of  onset,  more  negative  symptoms,  and 
greater  anticholinergic  medication  dosage. 
Another  study  found  that  the  patient’s 
performance  in  the  neuropsychological  tests 
correlated  with  dosage  of  neuroleptic  and 
anticholinergic  medication  [5].  They  found 
that  high  neuroleptic  and  anticholinergic 
dosages  were  associated  with  poor  verbal 
recognition memory. On the contrary, a meta-
analysis conducted on 70 studies of memory in 
schizophrenia  showed  that  the  memory 
impairment  is  stable,  wide  ranging,  and  not 
substantially affected by potential moderating 
factors  such  as  severity  of  psychopathology 
and duration of illness [6]. Thus, it is difficult 
to  ascertain  whether  the  observed  memory 
dysfunctions in schizophrenia were related to 
variation  in  age  of  onset,  educational  level, 
effects  of  the  illness  or  iatrogenic  effects  of 
pharmacotherapy. 
Thus, the present study aims to (i) assess and 
obtain  local  data  on  verbal  memory 
performance  in  patients  with  schizophrenia 
attending  HUSM  and  (ii)  determine  the 
relationship  between  the  patients’  verbal 
memory  performance  and  their 
demographic/clinical symptoms.
Methods
Subjects
This is a cross sectional study on 114 patients 
with  schizophrenia.  The  subjects  were 
conveniently  selected  from  the  outpatient 
clinic  and  psychiatric  wards  in  Hospital 
Universiti  Sains  Malaysia  (HUSM)  within  a 
six-month  period  (December  2007  till  May 
2008).  They  were  cooperative  and  able  to 
understand the Malay language. Patients were 
excluded if they scored 5 (moderately severe) 
or more in any of the Brief Psychiatric Rating 
Scale (BPRS)  item,  presence  of  a  central 
nervous system disease, mental retardation or 
were not testable due to acute psychotic state 
or severe medical co-morbidity. The age limit 
of  all  subjects  was  set  between  18  and  60 
years, to enable legal consent and to minimize 
the  effect  of  normal  aging  process  on  the 
cognitive  performance.  The  study  protocol 
was  approved  by  the  Research  &  Ethics 
Committee,  Universiti  Sains  Malaysia.  A 
single  researcher  trained  in  psychiatric 
interview  and  examination  administered  the 
test  and  interviewed  all  the  subjects 
individually. 
Assessments
The  patients’  verbal  learning  and  memory 
performance were assessed using the validated 
Malay  version  of  the  Auditory  Verbal 
Learning  Test,  MVAVLT  [7].  The  test  was 
administered to all subjects by the same rater 
(second author)  as  described earlier  [8].  The 
MVAVLT  consists  of  two  different  lists  (A 
and B)  of  15  concrete  nouns.  Subjects  were 
read list A five times (A1 to A5) at a rate of 
one item per second (tape recording was used 
to standardize the rate). Free verbal recall was 
tested  immediately  after  each  presentation. 
Then list B was presented followed by a free 
recall of list B. Thereafter, recall of list A (A6) 
was  examined  without  prior  presentation  of 
list A. Recall of list A (A7) was repeated again 
after  20  minutes  of  rest  without  prior 
presentation of list A. Finally, subjects had to 
recognize the words from list  A interspersed 
among  semantically  or  phonetically  related 
words in a third list  comprised of 30 words. 
BPRS  was  used  to  measure  positive 
symptoms,  general  psychopathology  and 
affective  symptoms  in  patients  with 
schizophrenia.  Sixteen  symptom  constructs 
were  originally  listed  for  rating  on  a  seven-
point scale (1 = not present, 7 = most severe), 
which document the intensity of symptoms in 
relatively  independent  areas.  The  rating  is 
based  upon  observations  made  by  the  rater 
during  a  15  to  30-minute  interview  (items 
which measure tension, emotional withdrawal, 
mannerisms  and posturing,  motor  retardation 
and  uncooperativeness),  and  subject  verbal 
report  (items  which  measure  conceptual 
disorganization,  unusual  thought  content, 
anxiety, guilt feelings, grandiosity, depressive 
mood, hostility, somatic concern, hallucinatory 
behaviour, suspiciousness and blunted affect). 
Subsequent  additions  to  the  scale  were  two 
additional  items  of  excitement  and 
disorientation.
The Malay version of The Calgary Depression 
Scale  for  schizophrenia (MVCDRS) 
(translated  by  psychiatrist,  Dr  Riana  Abdul 
Rahim) was used to assess  the  symptoms  of 
major  depressive  disorder  in  patients  with 
schizophrenia. The CDRS was first developed 
by  Addington  et  al.  (1990)  and  was 
specifically  designed  to  assess  co-morbid 
depressive  symptoms  in  patients  with 
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schizophrenia;  its  use  in  other  patient 
populations  has  not  been  tested.  The  CDRS 
consists  of  nine  items:  depressed  mood, 
hopelessness, self-deprecation, guilty ideas of 
reference,  pathological  guilt,  depression 
worsening  in  the  morning,  early  awakening, 
suicide,  and  observed  depression.  The  items 
on  the  CDRS  are  all  typical  depressive 
symptoms and do not appear to overlap with 
the negative symptoms of schizophrenia (e.g., 
anhedonia is not included as a CDRS item). 
Statistical Analysis
All  analyses  were  conducted  using  SPSS 
version  18.0.  The  scores  in  the  MVAVLT 
were  taken  as  dependent  variables.  The 
patients’  demographic  and  clinical 
characteristics  were  taken  as  independent 
variables.  Statistical  analysis  started  with 
descriptive  statistics  which  included 
frequency,  percentage,  mean,  standard 
deviation  and  range  accordingly  for 
demographic  characteristics,  clinical 
characteristics and MVAVLT scores for each 
domain  level.  Relationships  between 
MVAVLT  performance  and  demographic  as 
well as clinical characteristics were evaluated 
using Pearson Correlation.  A  p value of less 
than 0.05 was considered as significant.
Results
A  total  of  114  patients  with  schizophrenia, 
comprising of 68 males and 46 females, with a 
mean age of 34.6 (10.21) years were enrolled 
into the study. A majority of the patients were 
Malay  (97.4%),  single  (64.9%),  unemployed 
(51.8%)  and  received  education  up  to 
secondary school (78.9%) as shown in Table 
1.
Table 1. Demographic characteristics of schizophrenia patients attending HUSM 
Demographic
Variables
Group N (%) Mean (SD)
Age (years) 34.6 (10.21)
18 – 30 35 (30.7) 
30 – 40 47 (41.2)
41 – 60 32 (28.1)
Gender Male 68 (59.6)
Female 46 (40.4)
Race Malay 111 (97.4)
Chinese 1 (0.9)
Other 2 (1.8)
Marital status Single 74 (64.9)
Married 27 (23.7)
Divorced 13 (11.4)
Occupation Unemployed 59 (51.8)
Self employed 30 (26.3)
Government servant 17 (14.9)
Private sector 8 (7.0)
Education level Primary school 8 (7.0)
Secondary school 82 (71.9)
College / university 24 (21.1)
A majority of patients had duration of illness 
for at least 5 years (69.3%) and were treated 
with atypical antipsychotics (58.8%) whereby 
22.4% of them were on clozapine (Table 2). 
33.3%  of  patients  were  on  typical 
antipsychotics  and  the  remaining  patients 
(7.9%) received combination of typical depot 
injection  and  oral  atypical  antipsychotics. 
22.8% of patients were on regular benzhexol, 
an  anticholinergic  drug,  to  counteract  the 
extrapyramidal  symptoms  caused  by  the 
typical antipsychotics (Table 2). A majority of 
them  (63.2%)  were  compliance  to  the 
antipsychotics prescribed and attended regular 
clinic  follow-up  (62.3%).  A  majority  of  the 
patients (66.7%) had history of being admitted 
to  the  psychiatry  ward  at  least  twice. 
Concurrent  medical  illness  was  present  in 
8.8% of patients for which 7.0% of them were 
also on medication for their  illness.  9.6% of 
the patients had previous history of substance 
abuse.  All  patients  had  mild  to  moderate 
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illness as measured by BPRS score. 34.2% of 
them had BPRS score at least 30 to 50, while 
the  remaining  (65.8%)  scored  less  than  30. 
Depression as defined by the MVCDRS score 
of 7 or more was present in 5.3% of patients. 
Table 2. Clinical characteristics of patients with schizophrenia attending HUSM
Clinical variables Characteristics n (%)
Duration of illness (years) < 2 15 (13.2)
2 – < 5 20 (17.5)
5 - < 10 24 (21.1)
≥ 10 55 (48.2)
Types of antipsychotic Typical 38 (33.3)
Atypical /Clozapine 67 (58.8)/ 15 (22.4)
Both 9 (7.9)
Use of anticholinergic Yes /No 26 (22.8) /88 (77.2)
Follow up Regular /Defaulter 71 (62.3)/ 43 (37.7)
Drug compliance Yes /No 72 (63.2) /42 (36.8)
Concurrent medication Yes /No 8 (7.0) /106 (93.0)
Number of hospitalization < 2 38 (33.3)
2 - < 6 50 (43.9)
≥ 6 26 (22.8)
Concurrent medical illness With/ Without 10 (8.8) /104 (91.2)
History of substance abuse Yes/ No 11 (9.6) /103 (90.4)
BPRS score < 30 75 (65.8)
≥ 30 - 50 39 (34.2)
CDRS score 0 – 6 (no depression) 108 (94.7)
≥ 7 (depression) 6 (5.3)
The  mean  MVAVLT  score  were  5.0  (1.93) 
and 8.9 (2.57)  out  of  15 word lists  for both 
Trial A1 and Trial A5 respectively (Table 3). 
The  mean  score  for  Trial  A1-A5  Total  was 
35.6 (9.79) out of 75 word lists. As for Trial B, 
the  mean  score  (3.7  (1.50))  was  low  when 
compared to Trial A1. These might be due to 
the difficulty in shifting attention to the new 
task  after  five  learning  trials.  However, 
surprisingly the mean score for Trial A6 (7.5 
(2.89)) was higher than Trial A1 even though 
their  memories  had  been  interrupted  by  the 
new  word  list  (list  B).  The  mean  score  for 
delayed memory (Trial A7) was almost similar 
with the mean score of Trial A6 administered 
20  minutes  before.  These  showed  that  the 
schizophrenia  patients  still  had the ability to 
sustain the previous learning information. The 
performance for the recognition task was also 
good with a mean score of 12.6 (2.60). 
Table 3. Verbal memory and learning performance of patients with  schizophrenia attending 
HUSM psychiatric services
MAVLT trials Mean score (SD)
Schizophrenia patients
n=114
Healthy controls **
n=15
A1 (Trial 1) 5.0 (1.93) 8.5 (2.20) 
A5 (Trial 5) 8.9 (2.57) 12.2 (1.78) 
Total Learning 
(A1+A2+A3+A4+A5)
35.6 (9.79) 53.2 (7.72)
B (Trial 6) 3.7 (1.50) 5.0 (1.60) 
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A6 (Trial 7) 7.5 (2.89) 11.0 (2.51) 
A7 (Trial 8) 7.4 (2.71) 11.1 (2.49) 
Recognition (Trial 9) 12.6 (2.60) 14.3 (0.88) 
**Published data [7].
The verbal learning and memory performance 
was  assessed  using  Malay  version  Auditory 
Verbal Learning Test (MVAVLT).
Table  4.  The  relationship  between  MVAVLT  performance  and  demographic/clinical 
characteristics of patients with schizophrenia
A1 A5 Total 
Learning 
A6 A7 Recognition
Age 0.445 0.633 0.518 0.173 0.469 0.205
Gender 0.043* 0.410 0.210 0.090 0.193 0.681
Occupation 0.083 0.075 0.015* 0.377 0.571 0.302
Education level 0.013* 0.139 0.012* 0.335 0.382 0.056
Duration of Illness 0.204 0.699 0.714 0.293 0.754 0.479
Type of 
antipsychotic
0.718 0.131 0.312 0.712 0.481 0.577
Use of 
Anticholinergic
0.992 0.264 0.121 0.201 0.079 0.769
BPRS Score 0.020* < 0.001* < 0.001* < 0.001* < 0.001* 0.001*
After controlled 
for education and 
occupation
0.046 < 0.001* < 0.001* < 0.001* < 0.001* 0.001*
CDRS score 0.438 0.040* 0.193 0.361 0.153 0.913
* p < 0.05 was considered as statistically significant.
There  were  no  significant  relationships 
between age and MVAVLT performance in all 
indexes  measured  (Table  4).  There  was  a 
significant  relationship  between  gender  and 
mean score for Trial A1 (p = 0.043) but not in 
other trials. Males scored higher compared to 
females in Trial A1 and the mean difference 
between the two groups was 0.7 (95% CI = 
0.02  to  1.46).  Even  though  the  other  mean 
scores  were  not  significant,  the  results 
consistently  showed  that  males  outperform 
females  on  most  of  the  indexes  on  the 
MVAVLT.  Both  educational  level  and 
employment  status  showed  significant 
relationship  with  MVAVLT  performance. 
Patients  who  received  college/university 
education  scored  higher  compared  to  those 
who  received  primary/secondary  education 
and  the  mean  difference  between  the  two 
groups was 1.1 (95% CI = 0.24 to 1.96) for 
Trial A1 and 5.6 (95% CI = 1.28 to 9.98) for 
Trial  A1-A5  Total.  Similarly,  employed 
patients  scored  higher  compared  to 
unemployed patients in Trial A1-A5 Total and 
the mean difference between these two groups 
was 4.4 (95% CI = 0.90 to 7.95) for Trial A1-
A5 Total.  These  findings  reflect  that  patient 
with  schizophrenia  from  low  educational 
background  and  unemployed  had  more 
memory symptoms that subsequently impaired 
their  function.  However,  there  were  no 
significant  relationship  between  MVAVLT 
performance  in  all  indexes  measured  and 
duration  of  illness,  types  of  antipsychotic  or 
use of anticholinergic medication. There were 
significant  relationship  between  MVAVLT 
performance  in  all  indexes  measured  and 
BPRS  score  even  after  controlling  for 
occupational  status  and  educational  level 
effects.  The patients  with higher  total  BPRS 
score (30 to 50) performed worse compared to 
those  with  lower  BPRS  score  (<30)  in  all 
MVAVLT indexes. In contrast,  there was no 
significant  relationship  between  MVAVLT 
performance  in  all  indexes  measured  and 
patient’s  emotional  status  as  measured  by 
CDRS, except for Trial A5. 
Discussion
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The present study found that  performance of 
patients  with  schizophrenia  was  generally 
worse than healthy individuals [7] in measures 
of  total  learning,  immediate  memory, 
immediate memory after interruption using list 
B  and  delayed  recall.  Their  performance  on 
recognition  tests  was  not  severely  impaired. 
This  finding  was  consistent  with  previous 
studies [9, 10]. In addition, it was found that 
the deficits  in  recall  were  related to  reduced 
use  of  organizational  strategies  to  facilitate 
verbal encoding and retrieval [10]. The authors 
concluded  that  deficits  in  consistency  of 
learning over several trials, as well as a strong 
relationship  between  semantic  organizational 
strategies  and  reduced  learning  capacity, 
implicate  prefrontal  dysfunction  as  a 
contributor  to  verbal  memory  deficits  in 
schizophrenia. 
The  present  study  provides  information 
regarding  the  relationship  between  verbal 
memory  dysfunction  in  schizophrenia  with 
demographic  characteristics.  Most  of  the 
patient’s  demographic  characteristics 
including age, gender, ethnicity, marital status, 
illness  duration  (years),  number  of 
hospitalization,  follow  up,  drug  compliance, 
use  of  anticholinergic  drug  and  type  of 
antipsychotics  use  were  unrelated  to  verbal 
learning and memory performance except for 
patient’s  occupational  status  and  educational 
level. 
This  study  found  no  significant  relationship 
between the MVAVLT performance and age 
and this is inconsistent with previous studies 
[11, 12]. A study by Wiens and colleagues in 
1988 found a small but significant correlations 
between age and performance on Trials  3,  5 
and 6 [11]. Another study reported significant 
age  correlating  with  Trials  5,  6,  7  (delayed 
recall) and total learning in 600 subjects with 
seronegative  homosexual  and  heterosexual 
males [12]. In the present study, there was no 
consistent  score  observed  between  the  three 
age groups and the test  performance did not 
decline with age. 
In  the  present  study,  there  were  more  male 
than  female  patients,  68  (59.6%)  versus  46 
(40.4%).  This  is  a  potential  concern  since 
women generally perform better than men on 
verbal  tasks  in  particular  verbal  and  recall 
tasks  [13].  The  present  findings  were 
contradictory  to  previous  studies  [14,  15]. 
Studies  utilizing  the  California  Verbal 
Learning Test (CVLT) specifically found that 
women  tend  to  perform better  than  men  on 
immediate recall and list learning recognition 
test [14]. The large difference in sample size 
between  male  and  female  patients  with 
schizophrenia in this study could explain the 
different findings. However, studies have not 
been  able  to  consistently  replicate  gender 
effects  on  RAVLT  performance  [15].  Thus, 
this appears to be a marginal effect that is of 
limited  importance  in  interpreting  RAVLT 
results. 
There  was  significant  relationship  between 
memory  (immediate  memory  and  total 
learning) and educational level in the present 
study.  This  is  in  line  with  the  findings  by 
Query  and  Berger  in  1980  [16].  That  study 
found  that  education  correlated  significantly 
with  recognition  memory  (r  =  0.41)  and 
learning  (r  =  0.42)  [16].  However,  low 
correlations  of  education with RAVLT score 
were  observed  in  acute  spinal  cord  injured 
patients wherein significant correlations were 
seen only for mean scores of Trials 4 and 5. 
The  insignificant  relationship  between  other 
MVAVLT scores and educational level in the 
present study could be explained by the small 
sample  size  and  the  broad  classification  of 
educational level whereby a few of the patients 
did not really complete secondary or primary 
school  but  were  still  included  in  the  same 
group.  The  same  confounds  the  college  or 
university group in which a few of them did 
not complete their studies. Another strategy is 
to  classify  them  according  to  duration  of 
formal  education received.  However,  it  must 
be remembered that some of the patients who 
studied up to tertiary level had extended their 
study  for  several  semesters  only  to  fail  the 
course at the end.
Significant relationship between memory and 
occupational status was only observed in Total 
Learning (A1+A2+A3+A4+A5). Even though 
there  were  no  relationship  in  the  other 
MVAVLT scores with the occupational status, 
the  overall  performances  were  better  in  the 
employed  group.  This  finding  is  consistent 
with a review compiled by Green (1996) that 
emphasized the significance of verbal memory 
for  the  functional  outcome  in  schizophrenia 
[2].  The  classification  of  the  occupational 
status  should  be  more  precise  including  the 
type  of  jobs  and  the  duration  of  being 
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employed or unemployed. Some patients with 
schizophrenia may remain unemployed due to 
stigma or public perception of their inability to 
work  rather  than  due  to  their  cognitive 
impairment.
This  study  failed  to  identify  a  significant 
relationship between the type of antipsychotics 
used  and  MVAVLT  scores,  consistent  with 
previous  study [1].  Another  study,  however, 
suggested  that  clozapine  treatment  was 
superior to typical antipsychotic in improving 
cognitive  function  in  schizophrenia  [17].  In 
this study, 58.8% of patients received atypical 
antipsychotics  whereby  almost  a  quarter  of 
them  received  clozapine  due  to  treatment-
resistant  schizophrenia.  This  subgroup  of 
patients had a much more  severe illness and 
probably had more memory symptoms prior to 
clozapine  treatment  thus  resulting  in  lower 
MVAVLT  scores.  The  different  dosage  of 
antipsychotic  used  and  the  duration  of 
treatment  either  in  typical  or  atypical  group 
could  also  contribute  to  the  non-significant 
results  since  the  impairment  in  memory  in 
patients  with  schizophrenia  frequently 
correlate  with  the  high  dose  of  typical 
antipsychotic used.
Anticholinergic  medication  has  been 
associated  with  impaired  memory  function 
[18]  and  may  antagonize  the  therapeutic 
effects of antipsychotic medication on positive 
symptoms in schizophrenia [19]. The present 
study, however, failed to identify a significant 
relationship between the use of anticholinergic 
medication  with  MVAVLT  scores.  The 
regular  administration of  benzhexol  in  26 of 
114  schizophrenia  patients  cannot  explain 
group  differences  since  no  differences 
occurred between patients who were never or 
not  regularly  treated  with  benzhexol. 
However,  the  pattern  of  results  displayed  in 
the  present  study  showed  better  MVAVLT 
scores in a group of patients who never or not 
regularly  treated  with  benzhexol.  The  data 
obtained regarding the use of benzhexol in this 
study  was  very  subjective  whereby  the 
information  was  gathered  from  the  patients 
themselves  and  from  the  patients’  medical 
records. The information regarding the dosage 
and duration of benzhexol used are also useful. 
However, the usefulness of this approach is of 
limited value since many antipsychotics (e.g., 
chlorpromazine  and  quetiapine)  possess 
significant intrinsic anticholinergic activity. 
The  present  findings  also  did  not  show any 
relationship  between  duration  of  illness  and 
MVAVLT mean scores. These results indicate 
that  the  chronicity  of  the  illness  did  not  by 
itself  determine  memory  function  but  other 
additional  factors  can  also  impair  memory 
performance.  These  include  adherence  to 
medication,  dosage  and  type  of  medication 
used and severity of relapses. 
In  line  with  previous  studies,  the  present 
findings  found  significant  relationship 
between  severity  of  illness  as  measured  by 
BPRS and MVAVLT scores.  The higher the 
total  BPRS score,  the  worse  performance  in 
the  MVAVLT  indexes.  However,  this  study 
did  not  identify  whether  the  patient’s 
performance  was  related  to  specific 
symptomatology of  illness.  A study done by 
Moritz  and  colleagues  in  2001  found  that 
negative  symptom  was  strongly  correlated 
with  memory  dysfunction  before  and  after 
controlling for distractibility [20]. 
The  present  finding  failed  to  identify  a 
significant  relationship  between  depressive 
symptoms using CDRS and MVAVLT scores 
except  in  Trial  A5.  This  finding  was  in 
contrast to findings from other studies [20, 21, 
22].  Query  and  Megran  (1984)  found  that 
depression  (as  measured  by  the  MMPI) 
accounted for reduced performance on Trial 1 
[21] only. Hinkin et al. (1992) found that the 
Beck  Depression  Inventory  (BDI)  correlated 
only with Trial B in a sample of HIV patients 
[22]. Moritz et al. (2001) found that patients 
with depression and schizophrenia performed 
significantly  worse  than  healthy  controls  in 
both short  term and long term free  recall  as 
well  as  recognition  test  [20].  The  possible 
explanation to  the  contrast  in findings is  the 
small  sample  size  of  the  depressed group of 
schizophrenia  patients  as  compared  to  non-
depressed group in the present study. Some of 
the schizophrenia patients are very suggestible 
and  tend  to  admit  that  they  are  having  the 
symptoms.  The  other  possible  explanation is 
that the depression in schizophrenia might not 
be related to affective symptoms but may be 
related to somatic symptoms which were not 
measured in this study. 
Limitations of this study include small sample 
size;  unavailability  of  data  on  the  verbal 
memory performance before and at the time of 
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disease  onset  as  well  as  lack  of  control  for 
external  factors.  The  MVAVLT  is  ideally 
conducted in a quiet and comfortable room to 
minimize  distractions  and  interruptions. 
However,  it  is  difficult  to  ensure  an  ideal 
environment because this study was conducted 
in a clinic room during clinic session. 
In  conclusion,  schizophrenia  patients  in  the 
present  study  performed  significantly  worse 
than  healthy  controls  in  total  learning, 
immediate  memory  with  or  without 
interference  and  delayed  recall.  There  were 
significant  relationships  between  MVAVLT 
performance and patient’s occupational status 
as well as their educational level.  This study 
was able to identify a significant relationship 
between MVAVLT performance and severity 
of illness but not depressive symptoms.
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